| Authors: |
Goudsmit J; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Human Vaccines Project, New York, NY, USA., van den Biggelaar AHJ; Human Vaccines Project, New York, NY, USA. anita.vandenbiggelaar@gmail.com., Koudstaal W; Human Vaccines Project, New York, NY, USA., Hofman A; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Koff WC; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Human Vaccines Project, New York, NY, USA., Schenkelberg T; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Human Vaccines Project, New York, NY, USA., Alter G; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Mina MJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Wu JW; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. |
